Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.
Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.
复制标题
DOI:
10.1038/onc.2012.190
复制
发表时间:
2013-03-28
期刊:
影响因子:
8
通讯作者:
Stratakis, C. A.
中科院分区:
文献类型:
--
作者:
Palumbo, T.;Faucz, F. R.;Azevedo, M.;Xekouki, P.;Iliopoulos, D.;Stratakis, C. A.
关键词:
MicroRNAs have been involved in the pathogenesis of different types of cancer, however their function in pituitary tumorigenesis remains poorly understood. Cyclic-AMP (cAMP)-dependent protein kinase (PKA)-defective pituitaries occasionally form aggressive growth-hormone (GH)-producing pituitary tumors in the background of hyperplasia caused by haploinsufficiency of the PKA’s main regulatory subunit, PRKAR1A. The molecular basis for this development remains unknown. We have identified a 17-microRNA signature of pituitary tumors formed in the background of hyperplasia (caused in half of the cases by PRKAR1A-mutations). We selected two microRNAs on the basis of their functional screen analysis: inhibition of miR-26b expression and up-regulation of miR-128 suppressed the colony formation ability and invasiveness of pituitary tumor cells. Furthermore, we identified that miR-26b and miR-128 affected pituitary tumor cell behavior through regulation of their direct targets, PTEN and BMI1, respectively. In addition, we found that miR-128 through BMI1 direct binding on the PTEN promoter affected PTEN expression levels and AKT activity in the pituitary tumor cells. Taken together, we have identified a microRNA signature for GH-producing pituitary tumors and found that miR-26b and miR-128 regulate the activity of the PTEN-AKT pathway in these tumors. This is the first suggestion of the possible involvement of microRNAs regulating the PTEN-AKT pathway in GH-producing pituitary tumor formation in the context of hyperplasia or due to germline PRKAR1A defects.
登录
查看更多内容
影响因子:
64.5
作者:
Hatziapostolou M;Polytarchou C;Aggelidou E;Drakaki A;Poultsides GA;Jaeger SA;Ogata H;Karin M;Struhl K;Hadzopoulou-Cladaras M;Iliopoulos D
通讯作者:
Iliopoulos D
影响因子:
5.6
作者:
Bottoni, A;Piccin, D;Uberti, ECD
通讯作者:
Uberti, ECD
影响因子:
11.2
作者:
Iorio, MV;Ferracin, M;Croce, CM
通讯作者:
Croce, CM
影响因子:
11.2
作者:
Godlewski, Jakub;Nowicki, Michal O.;Lawler, Sean
通讯作者:
Lawler, Sean
影响因子:
11.5
作者:
Bandres, Eva;Bitarte, Nerea;Garcia-Foncillas, Jesus
通讯作者:
Garcia-Foncillas, Jesus